In patients with cirrhosis and HCC, the level of methionine adenosyltransferase (MAT1A), a crucial gene involved in the methionine metabolism, is downregulated, thereby leading to hypermethioninemia and reduced hepatic glutathione concentrations. This evidence concerns the gene MAT1A and hepatocellular carcinoma.